Global Legionella Testing Market
Global Legionella Testing Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
June 17, 2022 08:28 ET | Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Infection Surveillance Solutions Market
Insights on the Infection Surveillance Solutions Global Market to 2027 - by Component, Deployment Type, End-user and Region
June 07, 2022 08:13 ET | Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction
March 22, 2022 05:00 ET | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
February 17, 2022 17:42 ET | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis’ Novel Host-directed Human Protein for Inflammatory Diseases Geared for Growth in 2022
January 24, 2022 15:52 ET | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical-stage, private company developing therapies for infectious, inflammatory and degenerative diseases...
22157.jpg
Global Interventional Pulmonology Market Report 2021-2025 with Regional Analysis of Bronchoscopy Examination Procedures
January 20, 2022 05:03 ET | Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Interventional Pulmonology Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to...
22157.jpg
Insights on the Hospital-Acquired Infection Control Global Market to 2030 - Upsurge in Likelihood of Epidemic or Pandemic Outbreaks is Driving Growth
December 21, 2021 06:38 ET | Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Hospital-Acquired Infection Control Market by Product & Service and End User: Global Opportunity Analysis and Industry Forecast, 2022-2030" report...
22157.jpg
Global Infection Control Market 2021-2026: Surge in Growth for E-Beam Sterilization and Re-Introduction of Ethylene Oxide Sterilization
December 20, 2021 06:38 ET | Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Infection Control Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global infection control...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics to Present “Conquering Pneumonia and Systemic Inflammation with a Human Protein,” at the MACRO Trends Investor Conference in Belgium
October 29, 2021 15:44 ET | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory, and degenerative diseases...
22157.jpg
Global Infection Surveillance Solutions Market is Forecast to Reach $1.03 Billion by 2026, Rising at a CAGR of 15.2%
October 01, 2021 04:58 ET | Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Infection Surveillance Solutions Market by Software (Cloud-based), Service (Product Support, Maintenance, Implementation), End-user (Hospitals...